Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 3/20 | 0.43 |
| ▸ | MMP9 | P14780 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | FLT3 | P36888 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6014512 | 0.85 | HTR6 (0.44) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL6014557 | 0.84 | HTR6 (0.42) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL6014405 | 0.83 | HTR6 (0.48) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL700914 | 0.82 | MMP2 (0.51) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL6014544 | 0.82 | HTR6 (0.47) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL6014355 | 0.82 | MMP9 (0.48) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL6014500 | 0.81 | MMP2 (0.43) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL16267636 | 0.81 | HTR6 (0.37) | HTR6MMP2MMP9CA1CA2 | |
| SCHEMBL6014593 | 0.80 | ALDH1A1 (0.39) | HTR6MMP2MMP9MAPTFLT3 | |
| SCHEMBL6014472 | 0.79 | MMP2 (0.47) | HTR6MMP2MMP9CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1458760-B1 | ENTRAPPED BINDING PROTEINS AS BIOSENSORS | BECTON DICKINSON CO (US) | 2012-03-07 | — | — | EP | claimed |
| US-7851593-B2 | Binding proteins as biosensors | BECTON, DICKINSON AND COMPANY (US) | 2010-12-14 | — | — | US | claimed |
| US-20070281368-A1 | BINDING PROTEINS AS BIOSENSORS | HSIEH HELEN V | 2007-12-06 | — | — | US | claimed |
| WO-2005080988-A1 | BINDING PROTEINS AS BIOSENSORS | BECTON, DICKINSON AND COMPANY (US) | 2005-09-01 | — | — | WO | claimed |
| US-20050014290-A1 | Binding proteins as biosensors | BECTON, DICKINSON AND COMPANY | 2005-01-20 | — | — | US | claimed |
| US-12569679-B2 | Treatment delivery system | WearOptimo Pty Ltd (AU) | 2026-03-10 | — | — | US | disclosed |
| US-12487180-B2 | Device and methods for quantifying analytes introduction | Life Technologies Corporation (US) | 2025-12-02 | — | — | US | disclosed |
| EP-4633458-A1 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | Adaptyx Biosciences, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250120620-A1 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | Adaptyx Biosciences, Inc. | 2025-04-17 | — | — | US | disclosed |
| US-20250025078-A1 | ELECTRODE ARRANGEMENT | WearOptimo Pty Ltd (AU) | 2025-01-23 | — | — | US | disclosed |
| US-12109019-B2 | Systems and methods for analyte detection | Adaptyx Biosciences, Inc. (US) | 2024-10-08 | — | — | US | disclosed |
| WO-2024130117-A1 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | Adaptyx Biosciences, Inc. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2006108095-A9 | SERUM BIOMARKER FOR DISEASE AND METHODS OF USING SAME | UNIV MARYLAND (US) | 2006-11-23 | — | — | WO | disclosed |
| WO-2006110748-A2 | RESPONSE GENE TO COMPLEMENT 32 (RGC-32) IN DISEASE | THE UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006108095-A2 | SERUM BIOMARKER FOR DISEASE AND METHODS OF USING SAME | THE UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006063213-A2 | SERUM AMYLOID A PROTEIN IN INFLAMMATION AND OBESITY | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2006-06-15 | — | — | WO | disclosed |
| WO-2006023635-A2 | METHODS OF SCREENING PROTEINS | BECTON, DICKINSON AND COMPANY (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20060040327-A1 | Methods of screening proteins | AMISS TERRY | 2006-02-23 | — | — | US | disclosed |
| WO-2005080988-A1 | BINDING PROTEINS AS BIOSENSORS | BECTON, DICKINSON AND COMPANY (US) | 2005-09-01 | — | — | WO | disclosed |
| US-20050014290-A1 | Binding proteins as biosensors | BECTON, DICKINSON AND COMPANY | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569679-B2 | Treatment delivery system | PIEZO1, DSG1, KRT18 | HTR6 9/4885MMP2 123/4885MMP9 371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.